In this regard, our results support the fact that WNT5A and JNK are upregulated in NAFLD, triggering noncanonical WNT signaling that promotes liver damage [21], but we could not demonstrate that this pathway is increased in an advanced stage of NAFLD, such as NASH. This evidence concerns the gene WNT5A and metabolic dysfunction-associated steatohepatitis.